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Abstract
Background Laparoscopic surgery has potential for less
tumor cell spread because of the no-touch technique. We
assessed the effect of the surgical approach (open versus
no-touch laparoscopic) on the presence of tumor cells in
sentinel lymph nodes (SN) of patients with stage I and II
colorectal cancer.
Methods A single-center consecutive prospective series
of patients operated on for colorectal cancer was analyzed.
After conventional hematoxylin and eosin (H&E) staining,
107 patients without lymphatic metastases were included;
59 patients had open surgery, and 48 patients underwent
laparoscopic resection. Patients in the laparoscopic group
underwent a no-touch medial to lateral approach, whereas
the conventional lateral to medial approach was applied in
open surgery. A SN procedure was performed in all
patients. The SNs were immunohistochemically analyzed
for presence of occult tumor cells (OTC). According to the
American Joint Committee on Cancer (AJCC) these tumor
cells were divided into micrometastases (0.2–2 mm) or
isolated tumor cells (ITC,\0.2 mm).
Results In ten patients micrometastases were found,
equally distributed between the two groups. However, ITC
were more often found after open surgery (18 versus 5
patients, p = 0.03). Presence of OTC was related to depth
of tumor invasion and tumor diameter[3.5 cm. Logistic
regression analysis identiﬁed lymphovascular invasion as a
predictor for micrometastases [odds ratio (OR) 18.4],
whereas open resection was predictive for presence of ITC
(OR 3.3).
Conclusions No-touch medial to lateral laparoscopic
surgery results in less isolated tumor cells in lymph nodes
compared with open lateral to medial surgery in patients
with stage I and II colorectal cancer.
Keywords Occult tumor cells  SN procedure 
No-touch technique  Laparoscopic surgery
During intraoperative manipulation of colorectal carcino-
mas, levels of circulating tumor cells (CTC) can be dem-
onstrated in peripheral and portal blood [1]. Recently, it has
been demonstrated that the cumulative percentage of CTC
in peripheral and portal blood was signiﬁcantly lower after
laparoscopic resection in which no-touch technique was
used [2]. This term refers to the principal of early lym-
phovascular ligation before manipulation of the tumor. In
1966, Turnbull et al. showed that early ligation increased
survival rates [3]. A randomized trial suggested favorable
patient-free survival and overall survival rate, however
without signiﬁcant difference [4]. Today, the no-touch
technique is not considered the standard surgical approach
in open surgery. However in laparoscopic colorectal sur-
gery, no-touch principles can optimally be represented with
the preferable medial to lateral approach where the sup-
plying vessels are ligated before the tumor is manipulated.
If fewer CTC are detected in blood during laparoscopic
surgery, it can be hypothesized that the same holds true for
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lymphatic sinus. Based on the sentinel lymph node (SN)
concept in which the lymphatic drainage from the primary
tumor follows a speciﬁc order, we showed that OTC are
preferentially found in the SN of patients with colorectal
cancer [5].
The objective of this study is to assess the effect of the
surgical approach (i.e., open lateral to medial versus lap-
aroscopic no-touch medial to lateral approach) on levels of
occult tumor cells in sentinel lymph nodes of patients with
stage I and II colorectal cancer.
Patients and methods
Study population
A prospective consecutive series of patients operated on
between November 2006 and June 2009 were analyzed.
Only patients undergoing potentially curative resection for
biopsy-proven colorectal cancer were eligible. Patients
with solid organ metastases detectable by preoperative
radiological staging or intraoperative visualization were
excluded, as were patients with macrometastases on con-
ventional H&E slides. In total, 107 patients with stage I and
II colorectal cancer were included (Fig. 1).
In 87 patients the choice of open or laparoscopic
approach depended on the surgeon to whom the patient was
referred. Twenty patients also participated in a randomized
trial comparing open and laparoscopic surgery (ISRCTN:
79588422) [6]. All procedures were performed by experi-
enced colorectal surgeons performing more than 20 pro-
cedures each year. All laparoscopic procedures were
performed by one surgeon expert at laparoscopic surgery.
All these resections were performed according to the no-
touch isolation technique (i.e., medial to lateral approach
with early vessel ligation). Lateral to medial approach was
performed during open resection. Patients who had early
conversion, e.g., because of dense adhesions, were ana-
lyzed in the open group if the vascular trunk was not
ligated before mobilization of the bowel and the lateral to
medial approach was used.
The study was done in accordance with the guidelines of
the local ethics committee.
Sentinel node procedure
A SN procedure was performed in all patients. Ex vivo
sentinel lymph node mapping was used, as described pre-
viously in detail [7]. After resection, 0.5–2 ml patent blue
(depending on the volume of the tumor) was injected below
the subserosa, around the tumor, with the colonic specimen
left intact. The ﬁrst one to four blue lymph nodes were
identiﬁed as sentinel nodes and either dissected or marked
with a suture.
Pathological examination
The surgical resection specimens were analyzed immedi-
ately at the department of pathology using a standardized
protocol. Tumor stage and grading were classiﬁed
according to the sixth edition of the AJCC tumor–node–
metastasis (TNM) classiﬁcation [8]. All lymph nodes (SNs
and non-SNs) were stained with hematoxylin and eosin and
evaluated for tumor involvement.
ForhistologicallyprovenN0patients,threeserialsections
at 500-lm intervals were immunohistochemically stained
with three different monoclonal antibodies to reveal OTC.
The anti-epithelial cell antibody Ber-EP4, directed against
membrane glycoproteins (DAKO, The Netherlands), was
combinedwithtwoanticytokeratinantibodies:CK20withits
expression limited to gastrointestinal epithelial cells (Euro
Diagnostica, Arnhem, The Netherlands) and Cam5.2,
All patients  
with colorectal cancer 
N = 229 
N = 107 
N = 184 
Patients with T4 tumor or 
distant metastases 
N = 45 
Patients with metastases in 
lymph nodes after H&E 
N = 77 
Open resection 
N = 59 
Laparoscopic resection 
N = 48 
Early conversion 
N = 3 
Laparoscopic group 
N = 45 
Open group 
N = 62 
Fig. 1 Patient stream by application of inclusion criteria
Surg Endosc (2011) 25:3652–3657 3653
123directed against cytokeratin 7 and 8 expressed in all epithe-
lial cells (Becton and Dickinson, Alphen aan den Rijn, The
Netherlands).
Immunohistochemically detected cells with any of the
three antibodies were considered as OTC only when they
showed unequivocal morphological features of cancer
cells. These tumor cells within lymph nodes were subdi-
vided into two categories according to the AJCC revised
guidelines: tumor cell deposits between 0.2 mm and
2.0 mm were referred to as micrometastases, and those
smaller than 0.2 mm as isolated tumor cells (ITC) [9].
Statistical analysis
Statistical calculations were performed using the Statisti-
cal Software Package version 14.0 (SPSS Inc., Chicago,
IL, USA). Categorical variables were compared using the
chi-square test, while the t-test was used for continuous
data with normal distribution. Univariate logistic regres-
sion analysis was used to identify factors predictive for
detection of OTC in histologically proven N0 patients.
Method of resection, T-stage, differentiation grade, and
tumor diameter were selected a priori as important
cofactors in identiﬁcation of CTC. Since the limited
number of events (from a statistical point of view) meant
that only a restricted number of possible predictors could
be included [10], variables with multiple categories were
recoded into dichotomous variables by combining cate-
gories with comparable prognosis (T-stage: I and II versus
III and IV; differentiation grade: well and moderate ver-
sus poor). For tumor diameter, a cutoff of 35 mm was
decided upon, as suggested in a study of a speciﬁcally
constructed receiver-operating curve [11]. All tests were
performed two sided, and p\0.05 was considered sta-
tistically signiﬁcant. To determine the clinicopathological
characteristics predictive for presence of OTC, logistic
regression was performed.
Results
Characteristics of the study population
During the study period, 107 patients with stage I and II
colorectal cancer were included (Table 1). Sixty-two
patients were analyzed in the open group, whereas 45
patients were analyzed in the laparoscopic group (Fig. 1).
There were 48 right-sided colectomies, 5 left-sided colec-
tomies, 53 (recto)sigmoid resections, and 1 subtotal
colectomy.
The patient and tumor characteristics were not different
between the two patient groups, except for tumor size,
which was slightly larger in the open group (Table 1).
Immunohistochemical detection of occult tumor cells
A total of 208 SNs were analyzed. Ten patients had true
micrometastases of more than 0.2 mm in one or more SNs
(9.3%, pN1mi?), whereas ITC were found in 23 patients
(21.5%, pN0itc?). Presence of micrometastases was
equally distributed between the open and laparoscopic
groups (n = 5 in both groups) (Table 2).
In contrast, isolated tumor cells were more frequently
found in the conventional open resection group when
compared with the no-touch laparoscopic group. Eighteen
patients (29%) in the open group had ITC, compared with
ﬁve patients (11%) in the laparoscopic group. This results
in an absolute risk reduction for incidence of ITC of 18%
and a number needed to treat of six in favor of the lapa-
roscopic group (Table 2). One of the ﬁve patients in the
laparoscopic group with ITC had a larger cluster of
0.18 mm with evident signs of proliferation and stromal
reaction, which could therefore be considered as a micro-
metastasis, although we adhered to the quantitative char-
acteristics of the AJCC. ITC were most frequently found in
the sinuses of the lymph nodes, as would be expected when
these cells are considered as transiently shed cells with
limited lifespan.
Predictive factors for presence of occult tumor cells
A relation between presence of OTC and larger tumors
(both inﬁltration depth and tumor diameter) was found.
The occurrence of true micrometastases in the SN was
strongly related to lymphovascular invasion, irrespective
of surgical approach. However, this could not be dem-
onstrated for occurrence of isolated tumor cells. Presence
of these cells was only related to method of resection,
with odds ratio of 3.3 (1.1–9.6) for open lateral to medial
resection (Table 3).
Discussion
This study demonstrates that the incidence of isolated
tumor cells in lymph nodes of patients with stage I and II
colorectal cancer is lower after no-touch laparoscopic
resection when compared with lateral to medial open
resection. These results are in line with other studies
demonstrating reduced levels of CTC in peripheral and
portal blood during laparoscopic resection [2, 12]. This is
the ﬁrst study analyzing tumor cells in lymph nodes using
immunohistochemical techniques, thereby overcoming the
historically controversial issues regarding reliability and
reproducibility of CTC measurement in blood [13].
An advantage of analyzing OTC in lymph nodes is that
histology can be preserved, discriminating between OTC and
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ral or portal blood for CTC during surgery use reverse-trans-
criptase polymerase chain reaction (RT-PCR) or quantitative
real-timeRT-PCR.However,histologicalconﬁrmationislost
in these techniques, which harbors the danger of identifying
shed debris or hematopoietic cells as tumor cells.
The clinical relevance of our ﬁnding is hard to assess.
Although the prognostic role of OTC seems to be estab-
lished in metastasized breast, colon, and prostate cancer
patients [14–16], the clinical relevance of peroperatively
detected cells is still debated. So far, these cells are
generally considered to be transiently shed cells without
prognostic signiﬁcance. The metastatic process is extre-
mely inefﬁcient, involving survival in circulation or
lymphatics, arresting at a distant target organ, extravasation
into surrounding tissue, and survival in the foreign micro-
environment, followed by proliferation and induction of
angiogenesis while evading apoptotic death or immuno-
logical response [17]. Tumors can shed millions of cells
into the bloodstream daily, but it has been demonstrated
that only a small percentage of tumor cells (0.05%) can
survive and initiate a metastatic focus [17].
Table 1 Clinicopathological characteristics of the included patients
All patients (n = 107) Open group (n = 62) Laparoscopic group (n = 45) p Value
Age (years)
a 70 ± 11 70 ± 10 69 ± 12 0.8
Gender
Male
b 48 28 20 0.9
Female
b 59 34 25
Body mass index (kg/m
2)
c 26 (18–31) 24 (18–28) 26 (22–31) 0.7
Preoperative CEA level
c 2.2 (0.5–10) 2.4 (0.9–10) 2.2 (0.5–8.4) 0.2
Tumor location
b 0.2
Colon 87 53 34
Rectum 20 9 11
Tumor diameter (cm)
a 5.1 ± 2 4.2 ± 2.0 0.04
Number of resected lymph nodes
a 15.5 ± 7 15.5 ± 7 15.6 ± 7 1.0
Number of identiﬁed SN
a 2.0 ± 2 1.9 ± 2.1 2.1 ± 2.4 0.7
Depth of invasion
b 0.7
pT1 8 3 5
pT2 29 17 12
pT3 68 41 27
pT4 2 1 1
Differentiation grade
b 0.2
Well 9 5 4
Moderate 80 43 37
Poor 18 14 4
Lymphovascular invasion
b 0.1
Absent 97 54 43
Present 10 8 2
a Mean (SD)
b Absolute numbers
c Median (min.–max.)
Table 2 Presence of occult tumor cells in SN in patients with colorectal cancer: comparison between open and laparoscopic resection
All patients (n = 107) Open group (n = 62) Laparoscopic group (n = 45) p Value Difference (%)
Occult tumor cells 33 23 10
Micrometastases 10 5 5 0.6
0.2–2.0 mm 8% 11% –3% (–15 to 8%)
Isolated tumor cells 23 18 5 0.03
\0.2 mm 29% 11% 18% (3–33%)
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123In contrast, data on patients with breast cancer show that
OTC in sentinel lymph nodes are related to reduced 5-year
disease-free survival [18]. Cultured single cells from rib
marrow of patients with esophagogastric cancer were via-
ble when inoculated subcutaneously in athymic nude mice
[19]. In addition, in patients with colon cancer, improved
5-year survival rates were reported combined with reduced
frequency of cancer cells in portal blood using the open no-
touch isolation technique [3]. The only randomized trial on
no-touch technique in patients with colon cancer did not
show a signiﬁcant increase in disease-free survival, but
data demonstrated better results in all analyses for the no-
touch patient group (time to recurrence, incidence of liver
metastases, and disease-free survival) [4].
So far, several randomized trials comparing laparo-
scopic with open surgery with long-term follow-up did not
show survival differences [20, 21]. This would be in line
with our hypothesis that the decreased number of detected
ITC is merely a mechanical process depending on the
surgical approach, rather than being viewed as a prognostic
factor. Better disease-free survival was demonstrated in
one early trial comparing laparoscopic with open resection,
but this improvement was only seen in stage III patients,
and therefore these results cannot be compared with our
ﬁndings in histologically N0 patients [22].
Previously, it has been suggested that the decreased
detection rate of CTC could be attributed to early ligation
of the lymphovascular trunk (medial to lateral approach)
[2]. We have demonstrated in a previous study that OTC
are preferentially found in peritumoral SNs [5]. Since
lymphatic drainage to peritumoral lymph nodes is not
disturbed by early ligation, it is unlikely that solely a
medial to lateral approach would result in decreased
numbers of ITC. Therefore, our results suggest that pre-
dominantly the no-touch technique of the laparoscopic
approach explains the lower incidence of ITC when
compared with conventional open resection. Even without
demonstrated prognostic relevance, this would make lap-
aroscopic no-touch resection the treatment of choice for
patients with stage I and II colorectal cancer. The devel-
opment of all metastases will start with a single cell, and so
far there are no techniques available to predict the possible
survival of ITC. Although most cells will not survive cir-
culation and immunological responses, activation of blood
coagulation and relative immune suppression due to sur-
gical stress might enhance the metastatic potential of these
intraoperatively spilled cells [23, 24].
A major drawback of our study is the nonrandomized
comparison. However, the decrease in ITC is not likely to
be attributed to patient selection since patient and tumor
characteristics, carcinoembryonic antigen (CEA) levels,
and number of resected lymph nodes were comparable in
the two treatment groups. There was a difference in tumor
diameter, with smaller tumors in the laparoscopic group.
However, regression analysis showed no relation between
presence of ITC and tumor diameter. The only parameter
predictive for presence of ITC was method of resection,
with OR of 3.3 for open lateral to medial surgery.
Conclusions
Laparoscopic no-touch surgery results in fewer isolated
tumor cells in lymph nodes compared with open lateral to
medial surgery in patients with stage I and II colorectal
cancer. Although prospective survival analyses in these
patients with ITC and randomized trials should be awaited,
every attempt should be made to prevent worsening of the
prognosis of patients during surgery. In that respect, lapa-
roscopic resection with the no-touch technique may have
beneﬁts over open surgery in patients with stage I and II
colorectal cancer.
Table 3 Logistic regression analyses of predictors for presence of occult tumor cells, micrometastases (0.2–2.0 mm), and isolated tumor cells
(\0.2 mm) in histologically N0 patients with colorectal cancer
Variable Occult tumor cells Isolated tumor cells
OR
a (CI
b) p Value OR
a (CI
b) p Value
Method of resection Open versus laparoscopic 0.5 (0.20–1.16) 0.1 3.3 (1.11–9.63) 0.03
Depth of invasion pT3/4 versus pT1/2 2.5 (0.99–6.6) 0.06 2.2 (0.75–6.6) 0.2
Differentiation grade Poor versus well and moderate 2.1 (0.75–5.78) 0.2 2.1 (0.70–6.45) 0.2
Tumor diameter [3.5 cm versus\3.5 cm 2.7 (1.05–7.08) 0.04 1.7 (0.61–4.86) 0.3
Micrometastases Isolated tumor cells
Lymphovascular invasion Present versus absent 18.4 (4.0–85.1) \0.001 0.38 (0.05–3.16) 0.4
a Odds ratio
b 95% CI
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